19
Views
15
CrossRef citations to date
0
Altmetric
External Hyperthermic Treatments, Stop-Flow Perfusions and Hyperthermic Liver Perfusion

Liposomal Doxorubicin Combined with Regional Hyperthermia: Reducing Systemic Toxicity and Improving Locoregional Efficacy in the Treatment of Solid Tumors

, , , , , & show all
Pages 34-36 | Published online: 27 Oct 2016

References

  • Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 2001; 19 (14): 3312–3322.
  • Harrington KJ, Syrigos KN, Vile RG. Liposomally targeted cytotoxic drugs for the treatment of cancer. J Pharm Pharmacol 2002; 54 (12): 1573–1600.
  • Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999;15 (5): 345–370.
  • Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitives liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 1996; 36 (5): 1177–1187.
  • Ning S, Macleod K, Abra RM, Huang AH, Hahn G. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Rad Oncol Biol Phys 1994; 29 (4): 827–834.
  • Park JW, Stauffer P, Diederich C, et al. Hyperthermia (HT) + doxil significantly enhances drug delivery and efficacy in metastatic breast cancer of the chest wall (CW): a phase I/II study. Proc Am Soc Clin Oncol USA 2001; 20: 47a.
  • Dvorak J, Zoul Z, Melichar B, et al. Pegylated liposomal doxorubicin in combination with hyperthermia for treatment of skin metastases of breast carcinoma: a case report. Onkologie 2001; 24: 166–168.
  • Kouloulias VE, Dadoufas CE, Kouvaris JR, et al. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: A phase I/II trial. Clin Cancer Res 2002; 8 (2): 374–382.
  • Zoul Z, Filip S, Melichar B, Dvorak J, Odrazka K, Petera J. Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy - a pilot experience. Onkologie 2004; 27 (4): 385–388.
  • Secord AA, Jones E, Hahn CA, et al. Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer. Proc Am Soc Clin Oncol USA 2004; 23:469.
  • Dvorak J, Zoul Z, Melichar B, et al. Pegylated liposomal doxorubicin in combination with hyperthermia in treatment of skin metastasis of breast carcinoma: a case report. J Clin Gastroenterol 2002; 34 (1): 96–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.